Wyden Urges ADHD Drug Manufacturers to Boost Production or Relinquish Excess Quota to Help Shortage
August 04, 2023
August 04, 2023
WASHINGTON, Aug. 4 -- Sen. Ron Wyden, D-Oregon, issued the following news release and letter on Aug. 3, 2023:
U.S. Senator Ron Wyden, D-Ore., today urged manufacturers of much-needed amphetamine medications for attention deficit hyperactivity disorder (ADHD), including Adderall and generic equivalents, to either increase their manufacturing of these medications or relinquish their remaining quota allotment for the Drug Enforcement Agency (DEA) to redistribute to manufacturers wantin . . .
U.S. Senator Ron Wyden, D-Ore., today urged manufacturers of much-needed amphetamine medications for attention deficit hyperactivity disorder (ADHD), including Adderall and generic equivalents, to either increase their manufacturing of these medications or relinquish their remaining quota allotment for the Drug Enforcement Agency (DEA) to redistribute to manufacturers wantin . . .